PPARδ signaling regulates colorectal cancer

Curr Pharm Des. 2015;21(21):2956-9. doi: 10.2174/1381612821666150514104035.

Abstract

Peroxisome proliferator-activated receptorδ (PPARδ) belongs to the PPARs receptor family including PPARα, PPARδ, and PPARγ. PPARδ is a ligand-activated transcription factor that plays a critical role in regulating cancer progression. PPARδ-linked tumorigenesis was first identified in colorectal cancer, which is demonstrated by the following evidences, so PPARε is a potential drug target for colorectal cancer. In contrast, some observations show that PPARδ negatively regulates colorectal cancer event. In the present review, the recent progress of PPARδ signaling-mediated colorectal cancer is covered.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Colorectal Neoplasms / genetics*
  • Colorectal Neoplasms / physiopathology*
  • Humans
  • PPAR delta / drug effects
  • PPAR delta / genetics*
  • PPAR gamma
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Vascular Endothelial Growth Factor A / genetics
  • beta Catenin / genetics

Substances

  • Antineoplastic Agents
  • PPAR delta
  • PPAR gamma
  • Vascular Endothelial Growth Factor A
  • beta Catenin